Veloxis Pharmaceuticals Agrees to Pay Over $46M to Resolve Criminal and Civil Liability for Kickback Schemes
Veloxis Pharmaceuticals Inc., a drug manufacturer based in Cary, North Carolina, has agreed to pay over $46 million to resolve criminal and civil allegations that it paid kickbacks to induce prescriptions and purchases of Envarsus XR, a kidney transplant immunosuppression drug. Veloxis Has Entered Into a Deferred Prosecution Agreement and Will Pay the Largest Sunshine Act Recovery in History.
More About This Action
Action Details
- Date:Aug. 10, 2026
- Agency:U.S. Department of Justice and U.S. Attorney's Office, District of Massachusetts
-
Enforcement Types:
- Criminal and Civil Actions